Delivery of foreign antigens by engineered outer membrane vesicle vaccines. - Wikidata - wikimedia - TriplyDB

Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

http://www.wikidata.org/entity/Q33733590

about

Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection A Molecularly Complete Planar Bacterial Outer Membrane Platform Protecting enzymatic function through directed packaging into bacterial outer membrane vesicles High yield production process for Shigella outer membrane particles Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.Membrane vesicle production by Chlamydia trachomatis as an adaptive response The Therapeutic Benefit of Bacterial Membrane Vesicles.Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen.Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae.Vibrio cholerae: lessons for mucosal vaccine design.Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans Positional assembly of enzymes on bacterial outer membrane vesicles for cascade reactions The Anabaena sp. PCC 7120 Exoproteome: Taking a Peek outside the Box Modulating antibacterial immunity via bacterial membrane-coated nanoparticles Synthetic microbes as drug delivery systems.Potent and tumor specific: arming bacteria with therapeutic proteins.Identification of Outer Membrane Vesicles Derived from Orientia tsutsugamushi.Membrane Vesicles Released by a hypervesiculating Escherichia coli Nissle 1917 tolR Mutant Are Highly Heterogeneous and Show Reduced Capacity for Epithelial Cell Interaction and Entry Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity.Virus-mimetic nanovesicles as a versatile antigen-delivery system.Proteomic analysis and immunogenicity of Mannheimia haemolytica vesicles.New technologies in developing recombinant attenuated Salmonella vaccine vectors.Immunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections.Cytotoxic and Inflammatory Responses Induced by Outer Membrane Vesicle-Associated Biologically Active Proteases from Vibrio cholerae.Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45.Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro.Bio-inspired virus-like nanovesicle for effective vaccination.Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform.Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.Liposome-like Nanostructures for Drug Delivery.

P2860

Q26784233-AB7C028C-C365-40EB-9C37-30F519EC0370 Q27305883-49624F61-1BCF-4E1C-AB60-7494CF4D25BD Q27313030-A750401B-7030-44EE-B6A2-5203F2B6C9B1 Q27319739-C3CD6FA2-EDF9-42B0-AB26-41F3FD9FA721 Q28728768-4781B687-2486-4811-BDD5-E0E61ADB6B26 Q28831290-8B1A75BC-2C40-4D11-ADE9-21F6C876B064 Q30371303-5CB5B454-DE81-4C1D-ABC5-1CC2D44794D9 Q30398876-0F0A55FB-D006-43EB-9D73-BC3E87C251ED Q30496874-592D7740-FEA8-45AC-8591-999898FF2B97 Q33601907-F4EBC427-4484-443C-840C-89B937A1D0A7 Q33730339-BA6337B4-B75A-4697-BAFD-0FA1E9F56214 Q33839021-D974123F-7C39-4D78-B50E-F1EBF208CC5C Q34037511-50440B53-970B-4006-A6EA-CB98B8C0CD52 Q34334767-B12908D0-7F09-47FE-826F-F8E7533B4F2B Q34529570-9ED1C6FC-84CC-47E6-BBAF-26AC4BA45EB7 Q34562952-CE6FF904-32D6-477E-A73A-77C93A8B5072 Q34576021-686FFF88-7757-4291-9901-E727AF2FEE14 Q34641267-A85E5B2C-FEAE-459F-A850-C0B26DE311C8 Q34761285-76658685-6D68-43BD-A7DE-19141A193A9F Q35075755-BF605E1F-77CA-45E2-AFCB-73A839B7A707 Q35167315-8EFFAAA4-36B6-4785-8D93-22C66672F83F Q35334007-8D1E8EEB-BCE3-4781-BCB2-536C3E1E1779 Q35447934-7C0877A5-C6D4-4408-983D-D78DF33D7933 Q35541972-9B4576E6-6DB4-489D-82AF-8789A0B9FD60 Q35579375-D94C10E0-2234-4A7A-A468-8B09C1B96BFA Q35778551-3D912B32-3A3C-403F-98F8-90A820B71A3C Q36236540-911D6170-1D65-458F-96F8-28DEB9E5FBB8 Q36294442-F7D7C2A3-B493-4592-AA87-2BE572BED3B9 Q36300220-9AA271B4-FE5C-4D43-9CD9-AF286A2D1AAE Q36606754-89098B1B-531B-4195-B04B-8333B762C56D Q36653379-3DE24CA4-B6B7-4597-8DFB-D4CFD002AAB1 Q36676050-BD9516C1-5BAE-46F4-B643-79FAF79DF2F2 Q36888443-2F927B05-C8CB-49F0-B4B6-4B6294352490 Q36889732-B2E3897D-7C58-4FEF-83F6-5592FE2BD2FC Q37141141-4BCB2428-7F70-4A21-B1C1-825FF34A5F51 Q37197146-91D83413-A0AB-495A-9C2F-6A57AF4493C2 Q37307095-C293CBF2-4614-4D39-96FF-1E1F162F811E Q37353525-95C46CF0-75DA-4152-A68B-C3A9011088AC Q37416593-55FC8DE0-5AD4-4122-BE92-4F17A7CFB0ED Q37424654-0083C25C-95FE-4B41-B872-49D4AADFA27F

P2860

Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

http://www.wikidata.org/entity/Q33733590

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

@ast

Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

@en

type

label

Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

@ast

Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

@en

prefLabel

Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

@ast

Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

@en

P1433

Q33733590-0973FEFC-20F4-4561-B803-72A25D31FD87

P1476

Q33733590-B79AB336-51F9-4B42-BF43-4FD39B097BB3

P2093

Q33733590-0E226DB7-1693-4BE4-89FC-90C4B6AF9BEB

Q33733590-1AF8918A-61AA-45EE-9C11-C3F4344E5ACD

Q33733590-3732B86C-12D2-4B71-8AEA-1BB7A6A7553C

Q33733590-8B296818-9055-4FDB-AF1D-E44D17435508

Q33733590-B83401AC-661F-49D9-8A1A-499F96E98480

Q33733590-DC25F461-6D8E-4DA2-BA40-8FD6501B704D

P2860

Q33733590-0E411861-A8E5-4A22-B8A5-E808E8014C82

Q33733590-15F47EF0-DE3C-4716-B656-AF1CB05906C3

Q33733590-1630A4F4-2053-47BA-89C9-B54B8C506DE0

Q33733590-1B91189A-B54F-44D8-BCA9-AA3BD94C4649

Q33733590-1BEF2513-0949-4BF8-9836-49FA6A4E103B

Q33733590-274ABB6A-785D-482A-92BA-9B55DD02174F

Q33733590-288123FD-13D0-48F7-BEF6-49FFAAC807F2

Q33733590-29FB0955-AEB4-44BD-88A2-FE96D6F03C5B

Q33733590-47C67F0B-4670-4C88-892C-2F058573E2DF

Q33733590-48E735A4-3E90-4F87-9AB8-487196C4F709

P304

Q33733590-8E74907D-97C3-4101-8056-C3B0EB587F5F

P31

Q33733590-82125830-8452-4017-A610-1EE6E272814D

P356

Q33733590-B973FA3F-DAF9-408D-B360-0EC9ADA37839

P407

Q33733590-76327E82-5CAD-43BE-A45E-4FAEA4B84737

P433

Q33733590-3B704E7F-16E1-4083-B3B5-5C0D2EA944D3

P478

Q33733590-224EC6FE-8838-43E2-8244-38210F44B0EA

P50

Q33733590-6BF02457-6746-45B8-8CA9-06CA6AF3A141

P577

Q33733590-801E37AE-74CD-4E77-9386-AC9143B2BAA9

P5875

Q33733590-B4672102-1529-4057-8007-3469D0999E53

P698

Q33733590-18248913-36C4-4A59-AEC4-CFAE6C634B90

P932

Q33733590-472A0FEB-A1CC-4729-BD51-9CDA363526DD

P356

PNAS.0805532107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

@en

P2093

Anne M Doody

http://www.w3.org/2001/XMLSchema#string

David J Chen

http://www.w3.org/2001/XMLSchema#string

David Putnam

http://www.w3.org/2001/XMLSchema#string

Elizabeth Buckles

http://www.w3.org/2001/XMLSchema#string

Matthew P DeLisa

http://www.w3.org/2001/XMLSchema#string

Stephan M Metzger

http://www.w3.org/2001/XMLSchema#string

P2860

Structures of gram-negative cell walls and their derived membrane vesicles

Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7

FACS-optimized mutants of the green fluorescent protein (GFP)

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.

Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response.

Bacterial outer membrane vesicles and the host-pathogen interaction.

Cytotoxin ClyA from Escherichia coli assembles to a 13-meric pore independent of its redox-state.

Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine

Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex.

Recent advances in the discovery and delivery of vaccine adjuvants.

P304

3099-3104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0805532107

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Nikolaus Osterrieder

P577

2010-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41408592

http://www.w3.org/2001/XMLSchema#string

P698

20133740

http://www.w3.org/2001/XMLSchema#string

P932

2840271

http://www.w3.org/2001/XMLSchema#string